Bisolvine Liquid
NDC Package 53145-402-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Bisolvine (dextromethorphan, guaifenesin) liquids is do not exceed 6 doses in 24 hours Age Dose Adults and children 12 years of age and more 2 teaspoonfuls (30 ml) every 4 hours Children under 12 years of age Consult your doctor. This formulation utilizes a liquid delivery system. Marketed by Menper Distributors Inc., this product is identified by NDC 53145-402 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
53145-402-06
Package Description
1 BOTTLE in 1 CARTON / 180 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
53145040206
RxNorm Crosswalk
  • RxCUI: 1298228 - dextromethorphan HBr 10 MG / guaiFENesin 100 MG in 15 mL Oral Solution
  • RxCUI: 1298228 - dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.67 MG/ML Oral Solution
  • RxCUI: 1298228 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 15 ML Oral Solution
  • RxCUI: 1298228 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 30 ML Oral Solution

Clinical Specifications

Proprietary Name
Bisolvine Aloe-miel
Non-Proprietary Name
Dextromethorphan, Guaifenesin
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Do not exceed 6 doses in 24 hours Age Dose Adults and children 12 years of age and more 2 teaspoonfuls (30 ml) every 4 hours Children under 12 years of age Consult your doctor

Regulatory & Marketing

Labeler Name
Menper Distributors Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53145-402-06 identifies a specific commercial package of 1 bottle in 1 carton / 180 ml in 1 bottle of Bisolvine Aloe-miel, a human over the counter drug labeled by Menper Distributors Inc.. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Menper Distributors Inc. on January 01, 2019. The current certification is valid through December 31, 2026.

How is this Menper Distributors Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53145040206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53145-402-06
11-Digit CMS (5-4-2)
53145-0402-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.